Natco Pharma zooms on starting Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment
Natco Pharma is currently trading at Rs. 1105.00, up by 114.20 points or 11.53% from its previous closing of Rs. 990.80 on the BSE. The scrip opened at Rs. 1188.95 and has touched a high and low of Rs. 1188.95 and Rs. 1100.00 respectively. So far 109062 shares were traded on the counter. The BSE … Read more